Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhalchandra V Joshi

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Circulation Research|March 18, 2006
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarctionAnna-Karin Wihlborg, Johanna Balogh, Lingwei Wang, et al.
Biochemical Pharmacology|October 13, 2004
Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptorMarco Cattaneo, Anna Lecchi, Michihiro Ohno, et al.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moietyZhan-Guo Gao, Bhalchandra V Joshi, Athena M Klutz, et al.
Nature|April 6, 2007
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosisSchuichi Koizumi, Yukari Shigemoto-Mogami, Kaoru Nasu-Tada, et al.
Nuclear Medicine and Biology|February 3, 2009
Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomographyDale O Kiesewetter, Lixin Lang, Ying Ma, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring systemArtem Melman, Ben Wang, Bhalchandra V Joshi, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Bioorganic & Medicinal Chemistry|June 9, 2009
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucoseHyojin Ko, Arijit Das, Rhonda L Carter, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Circulation Research|March 18, 2006
Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarctionAnna-Karin Wihlborg, Johanna Balogh, Lingwei Wang, et al.
Biochemical Pharmacology|October 13, 2004
Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptorMarco Cattaneo, Anna Lecchi, Michihiro Ohno, et al.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moietyZhan-Guo Gao, Bhalchandra V Joshi, Athena M Klutz, et al.
Nature|April 6, 2007
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosisSchuichi Koizumi, Yukari Shigemoto-Mogami, Kaoru Nasu-Tada, et al.
Nuclear Medicine and Biology|February 3, 2009
Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomographyDale O Kiesewetter, Lixin Lang, Ying Ma, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring systemArtem Melman, Ben Wang, Bhalchandra V Joshi, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Bioorganic & Medicinal Chemistry|June 9, 2009
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucoseHyojin Ko, Arijit Das, Rhonda L Carter, et al.
Pageof 3